Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Fresenius Medical Care AG & Co. KGaA
  6. Summary
    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 06/21 11:47:00 am
69.44 EUR   -1.00%
06/17FRESENIUS SE  : Deutsche Bank reiterates its Neutral rating
MD
06/10FRESENIUS SE  : Buy rating from Goldman Sachs
MD
06/10PRESS RELEASE : SphingoTec Expands Management Team and Appoints new CFO
DJ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
06/15/2021 06/16/2021 06/17/2021 06/18/2021 06/21/2021 Date
69.36(c) 69.98(c) 70.22(c) 70.14(c) 69.5 Last
471 242 662 921 529 614 1 414 137 419 613 Volume
+0.55% +0.89% +0.34% -0.11% -0.91% Change
More quotes
Financials (USD)
Sales 2021 21 617 M - -
Net income 2021 1 345 M - -
Net Debt 2021 13 952 M - -
P/E ratio 2021 18,2x
Yield 2021 1,71%
Sales 2022 22 633 M - -
Net income 2022 1 541 M - -
Net Debt 2022 13 186 M - -
P/E ratio 2022 15,6x
Yield 2022 1,90%
Capitalization 24 363 M 24 355 M -
EV / Sales 2021 1,77x
EV / Sales 2022 1,66x
Nbr of Employees 124 995
Free-Float 67,8%
More Financials
Company
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines,... 
Read more
More about the company
Ratings of Fresenius Medical Care AG & Co. KGaA
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
06/17FRESENIUS SE  : Deutsche Bank reiterates its Neutral rating
MD
06/10FRESENIUS SE  : Buy rating from Goldman Sachs
MD
06/10PRESS RELEASE : SphingoTec Expands Management Team and Appoints new CFO
DJ
06/09DGAP-DD : Fresenius Medical Care AG & Co. KGaA english
DJ
06/08FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs reiterates its Buy rating
MD
06/07PRESS RELEASE : MagForce AG Supports World Brain Tumor Day and Informs about Var..
DJ
06/02ANALYST RECOMMENDATIONS : Bank of America, Bodycote, Chevron, Dow Inc, Ferguson...
06/01FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies gives a Sell rating
MD
06/01FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs maintains a Buy rating
MD
06/01FRESENIUS SE  : Goldman Sachs reaffirms its Buy rating
MD
05/31FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 41 of the Wp..
EQ
05/26DGAP-DD : Fresenius Medical Care AG & Co. KGaA english
DJ
05/26PRESS RELEASE : Immatics Announces Changes to its Board of Directors
DJ
05/24SECTOR UPDATE : Health Care Stocks Still Narrowly Higher in Late Regular-Hours T..
MT
05/24SECTOR UPDATE : Health Care Stocks Higher in Moderation
MT
More news
News in other languages on FRESENIUS MEDICAL CARE AG & CO. KGAA
06/15MÄRKTE EUROPA/DAX vor Fed-Sitzung weiter freundlich
06/14Nestlé fait entrer un représentant du WWF au sein d'un de ses organes
06/14STUDI LEGALI  : Legance con Ihg in cessione ramo dialisi
06/11MILAN STOCK EXCHANGE : Borsa Milano indici quasi fermi, strappano Reno Medici, I..
06/11MÄRKTE EUROPA/Gut behauptet - fallende Renditen stützen
More news
Analyst Recommendations on FRESENIUS MEDICAL CARE AG & CO. KGAA
More recommendations
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 80,08 $
Last Close Price 83,18 $
Spread / Highest target 16,2%
Spread / Average Target -3,73%
Spread / Lowest Target -55,5%
EPS Revisions
Managers and Directors
NameTitle
Rice Powell Chief Executive Officer
Helen Giza Chief Financial Officer
Dieter Schenk Chairman-Supervisory Board
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS MEDICAL CARE AG & CO. KGAA2.84%24 355
CVS HEALTH CORPORATION20.64%108 485
HCA HEALTHCARE, INC.22.44%66 581
REDE D'OR SÃO LUIZ S.A.-1.99%25 756
LABORATORY CORPORATION OF AMERICA HOLDINGS27.83%25 405
QUEST DIAGNOSTICS INCORPORATED6.99%16 656